Temasek Holdings’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $180M | Hold |
7,012,974
| – | – | 0.48% | 40 |
|
|
2026
Q1 | $135M | Hold |
7,012,974
| – | – | 0.44% | 43 |
|
|
2025
Q4 | $116M | Buy |
7,012,974
+1,657,142
| +31% | +$28M | 0.37% | 50 |
|
|
2025
Q3 | $77.8M | Hold |
5,355,832
| – | – | 0.27% | 57 |
|
|
2025
Q2 | $74.9M | Hold |
5,355,832
| – | – | 0.29% | 52 |
|
|
2025
Q1 | $72.8M | Hold |
5,355,832
| – | – | 0.29% | 47 |
|
|
2024
Q4 | $109M | Hold |
5,355,832
| – | – | 0.43% | 36 |
|
|
2024
Q3 | $156M | Sell |
5,355,832
-350,513
| -6% | -$8.69M | 0.63% | 30 |
|
|
2024
Q2 | $133M | Hold |
5,706,345
| – | – | 0.62% | 32 |
|
|
2024
Q1 | $117M | Sell |
5,706,345
-1,189,647
| -17% | -$22.4M | 0.65% | 28 |
|
|
2023
Q4 | $148M | Hold |
6,895,992
| – | – | 0.83% | 28 |
|
|
2023
Q3 | $142M | Hold |
6,895,992
| – | – | 0.85% | 28 |
|
|
2023
Q2 | $204M | Hold |
6,895,992
| – | – | 1.18% | 24 |
|
|
2023
Q1 | $159M | Buy |
6,895,992
+379,951
| +6% | +$10.5M | 0.94% | 25 |
|
|
2022
Q4 | $181M | Buy |
6,516,041
+940,000
| +17% | +$28M | 1.06% | 27 |
|
|
2022
Q3 | $171M | Buy |
5,576,041
+206,554
| +4% | +$6.72M | 1.02% | 29 |
|
|
2022
Q2 | $158M | Hold |
5,369,487
| – | – | 0.87% | 28 |
|
|
2022
Q1 | $173M | Hold |
5,369,487
| – | – | 0.73% | 32 |
|
|
2021
Q4 | $239M | Hold |
5,369,487
| – | – | 0.86% | 29 |
|
|
2021
Q3 | $271M | Buy |
5,369,487
+959,030
| +22% | +$54.1M | 0.95% | 24 |
|
|
2021
Q2 | $346M | Hold |
4,410,457
| – | – | 1.16% | 23 |
|
|
2021
Q1 | $252M | Hold |
4,410,457
| – | – | 0.99% | 23 |
|
|
2020
Q4 | $369M | Hold |
4,410,457
| – | – | 1.59% | 14 |
|
|
2020
Q3 | $158M | Hold |
4,410,457
| – | – | 0.8% | 23 |
|
|
2020
Q2 | $107M | Hold |
4,410,457
| – | – | 0.64% | 26 |
|
|
2020
Q1 | $77.2M | Hold |
4,410,457
| – | – | 0.57% | 24 |
|
|
2019
Q4 | $76.8M | Hold |
4,410,457
| – | – | 0.5% | 29 |
|
|
2019
Q3 | $67.6M | Hold |
4,410,457
| – | – | 0.5% | 30 |
|
|
2019
Q2 | $91.6M | Hold |
4,410,457
| – | – | 0.65% | 29 |
|
|
2019
Q1 | $102M | Hold |
4,410,457
| – | – | 0.71% | 25 |
|
|
2018
Q4 | $91.1M | Hold |
4,410,457
| – | – | 0.63% | 27 |
|
|
2018
Q3 | $95.9M | Hold |
4,410,457
| – | – | 0.56% | 35 |
|
|
2018
Q2 | $67.3M | Hold |
4,410,457
| – | – | 0.35% | 39 |
|
|
2018
Q1 | $86.8M | Hold |
4,410,457
| – | – | 0.48% | 31 |
|
|
2017
Q4 | $69M | Buy |
+4,410,457
| New | +$79.3M | 0.42% | 33 |
|
Other funds holding DNLI
Temasek Holdings's DNLI Position: Q2 2026 in Review
Temasek Holdings held its Denali Therapeutics (DNLI) position steady in Q2 2026 at 7,012,974 shares worth $180M. The position accounts for 0.48% of the portfolio, ranked #40.
Temasek Holdings first reported a position in DNLI in Q4 2017 and has held it in 35 quarters since. The position peaked at $369M in Q4 2020. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.
- Temasek Holdings held 7,012,974 shares of Denali Therapeutics worth $180M as of Q2 2026.
- Temasek Holdings left its Denali Therapeutics share count unchanged in Q2 2026.
- Denali Therapeutics made up 0.48% of Temasek Holdings's portfolio in Q2 2026, its #40 holding.
- Temasek Holdings first reported a position in Denali Therapeutics in Q4 2017 and has held it in 35 quarters since.
- Temasek Holdings's Denali Therapeutics position peaked at $369M in Q4 2020.
- 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.
Based on Temasek Holdings's 13F filing for Q2 2026, filed 7 Aug 2026.